Publications by authors named "Alexander Scheer"

Claim this Profile
M
Multiparametric characterization of red blood cell physiology after hypotonic dialysis based drug encapsulation process.
Mélanie Robert, Bastien Laperrousaz, Diana Piedrahita, Emilie-Fleur Gautier, Travis Nemkov, Alexander Scheer

Acta Pharm Sin B· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a 10 km running trial on eryptosis, red blood cell rheology, and electrophysiology in endurance trained athletes: a pilot study.
Elie Nader, David Monedero, Mélanie Robert, Sarah Skinner, Emeric Stauffer, Alexander Scheer

Eur J Appl Physiol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and optimization of an aminoalcohol-carbazole series with antimalarial properties.
Jérôme Molette, Julie Routier, Nada Abla, Dominique Besson, Agnes Bombrun, Alexander Scheer

ACS Med Chem Lett· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mining biomarker information in biomedical literature.
Erfan Younesi, Luca Toldo, Bernd Müller, Christoph M Friedrich, Natalia Novac, Alexander Scheer

BMC Med Inform Decis Mak· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycosaminoglycan analogs as a novel anti-inflammatory strategy.
India C Severin, Adriano Soares, Jennifer Hantson, Mauro Teixeira, Daniela Sachs, Alexander Scheer

Front Immunol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building a disease knowledge environment to lay the foundations for in silico drug discovery and translational medicine.
Caroline S Kant, Mark R Ibberson, Alexander Scheer

Expert Opin Drug Discov· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of novel small molecules as potent inhibitors of the plasmodial calcium-dependent protein kinase 1.
Guillaume Lemercier, Amaury Fernandez-Montalvan, Jeffrey P Shaw, Dominik Kugelstadt, Joerg Bomke, Alexander Scheer

Biochemistry· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy.
Kayode K Ojo, J Robert Gillespie, Aaron J Riechers, Alberto J Napuli, Christophe L M J Verlinde, Alexander Scheer

Antimicrob Agents Chemother· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a new class of potent, selective, and orally bioavailable CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.
Stefano Crosignani, Patrick Page, Marc Missotten, Véronique Colovray, Christophe Cleva, Alexander Scheer

J Med Chem· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arrest of preterm labor in rat and mouse by an oral and selective nonprostanoid antagonist of the prostaglandin F2alpha receptor (FP).
Rocco Cirillo, Enrico Gillio Tos, Patrick Page, Marc Missotten, Anna Quattropani, Alexander Scheer

Am J Obstet Gynecol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G protein-coupled receptor-mediated ERK1/2 phosphorylation: towards a generic sensor of GPCR activation.
Didier Leroy, Marc Missotten, Caroline Waltzinger, Thierry Martin, Alexander Scheer

J Recept Signal Transduct Res· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A microfluidics-based mobility shift assay to discover new tyrosine phosphatase inhibitors.
Dominique Perrin, Christèle Frémaux, Dominique Besson, Wolfgang H B Sauer, Alexander Scheer

J Biomol Screen· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cellular assay for measuring the modulation of glucose production in H4IIE cells.
Anne-Marie de Raemy-Schenk, Solenne Troublé, Pascale Gaillard, Patrick Page, Jean-Pierre Gotteland, Alexander Scheer

Assay Drug Dev Technol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future trends in screening technology for drug discovery.
Alexander Scheer

Expert Opin Drug Discov· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cellular assay for measuring the inhibition of glycogen synthase kinase-3 via the accumulation of beta-catenin in Chinese hamster ovary clone K1 cells.
Karen Yeow, Laurence Novo-Perez, Pascale Gaillard, Patrick Page, Jean-Pierre Gotteland, Alexander Scheer

Assay Drug Dev Technol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assay development and screening of a serine/threonine kinase in an on-chip mode using caliper nanofluidics technology.
Dominique Perrin, Christèle Frémaux, Alexander Scheer

J Biomol Screen· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular imaging in drug discovery.
Paul Lang, Karen Yeow, Anthony Nichols, Alexander Scheer

Nat Rev Drug Discov· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming the hurdle of fluorescent compounds in kinase screening: a case study.
Dominique Perrin, Thierry Martin, Yves Cambet, Christèle Frémaux, Alexander Scheer

Assay Drug Dev Technol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and development of a new class of potent, selective, orally active oxytocin receptor antagonists.
Anna Quattropani, Jérôme Dorbais, David Covini, Pierre-André Pittet, Véronique Colovray, Alexander Scheer

J Med Chem· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The DRY motif as a molecular switch of the human oxytocin receptor.
Nicolas Favre, Francesca Fanelli, Marc Missotten, Anthony Nichols, Janet Wilson, Alexander Scheer

Biochemistry· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Studies on G-protein alpha.betagamma heterotrimer formation reveal a putative S-prenyl-binding site in the alpha subunit.
Alexander Dietrich, Alexander Scheer, Daria Illenberger, Yoel Kloog, Yoav I Henis

Biochem J· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A homogeneous 384-well high-throughput binding assay for a TNF receptor using alphascreen technology.
Janet Wilson, Claudia Pena Rossi, Susanna Carboni, Christèle Fremaux, Dominique Perrin, Alexander Scheer

J Biomol Screen· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacology of (2S,4Z)-N-[(2S)-2-hydroxy-2-phenylethyl]-4-(methoxyimino) -1-[(2'-methyl[1,1'-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a new potent and selective nonpeptide antagonist of the oxytocin receptor.
Rocco Cirillo, Enrico Gillio Tos, Matthias K Schwarz, Anna Quattropani, Alexander Scheer

J Pharmacol Exp Ther· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis